Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Cidara Therapeutics Receives Breakthrough Therapy Designation for CD388 in Preventing Seasonal Influenza
Friday, October 10, 2025Cidara Therapeutics has received Breakthrough Therapy designation from the US Food and Drug Administration FDA for CD
Celltrion Receives Approval for EYDENZELT® (aflibercept-boav), a Biosimilar to EYLEA® (aflibercept)
Friday, October 10, 2025Celltrion has received approval from the US Food and Drug Administration FDA for EYDENZELT afliberceptboav a biosimilar referencing EYLEA aflibercept
Kazia Therapeutics Secures Collaboration and In-Licensing for First-in-Class PD-L1 Protein Degrader Program
Thursday, October 09, 2025Kazia Therapeutics Limited an oncologyfocused drug development company has entered an exclusive collaboration and inlicensing agreement with QIMR Berghofer for a firstinclass PDL degrader programme
Werewolf Therapeutics Receives FDA Fast Track Designation for WTX-124 in Advanced Melanoma
Thursday, October 09, 2025Werewolf Therapeutics Inc a company developing immunestimulating therapies for cancer and other immunerelated conditions has received Fast Track Designation from the US Food and Drug Administration FDA
JCR Pharmaceuticals Advances Gene Therapy Delivery to CNS and Muscle with Novel Capsid Technology
Wednesday, October 08, 2025JCR Pharmaceuticals Co Ltd a global biopharmaceutical company focused on therapies for rare and genetic diseases has presented nonclinical data showing that its proprietary JUSTAAV capsid engineering platform
MOLCURE Partners with Boehringer Ingelheim to Develop Next-Generation Antibody Drugs Using AI-driven Technology
Tuesday, October 07, 2025MOLCURE Inc has entered into a multiyear strategic research partnership with Boehringer Ingelheim to discover and develop innovative antibody therapies for multiple targets through its proprietary AIdriven platform
Algen Biotechnologies Enters into Partnership with AstraZeneca to Advance AI-Driven Drug Discovery in Immunology
Monday, October 06, 2025Algen Biotechnologies has entered into a multitarget partnership with AstraZeneca to accelerate the discovery of new therapeutic targets in immunology
Hikma and Celltrion expand collaboration to enhance biosimilar availability in MENA
Monday, October 06, 2025Hikma Pharmaceuticals has strengthened its partnership with Celltrion through new exclusive licensing agreements across the Middle East and North Africa MENA region
Taysha Gene Therapies Receives Breakthrough Therapy Designation and Reports Regulatory Progress on TSHA-102 in Rett Syndrome
Friday, October 03, 2025Taysha Gene Therapies has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to TSHA its investigational gene therapy for Rett syndrome
Bristol Myers Squibb’s Alzheimer’s Candidate BMS-986446 Receives FDA Fast Track Designation
Friday, October 03, 2025Bristol Myers Squibb has announced that the US Food and Drug Administration FDA has granted Fast Track Designation to BMS an investigational antibody targeting the microtubule binding region of tau MTBRtau
